Description
GLP-3-R is a novel triple-action receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. Clinical research has demonstrated significant results in metabolic function and body composition studies.
Desired Effects
- Fat Loss
- Appetite Control
- Blood Sugar Support
- Metabolic Function
- GLP-1 / GIP / GCGR Agonist
- Energy Expenditure
Purity: 99.5% | Janoshik Tested | USA Based
For research use only. Not for human consumption.
Certificate of Analysis
Independent third-party HPLC lab test by Janoshik Analytical. Every batch is tested before release.
Click to view full-size lab report.
Read the full research & mechanism writeup on Retatrutide (GLP-3-R) →



Reviews
There are no reviews yet.